Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13
Frequently Asked Questions
What is Market Cap of Oramed Pharmaceuticals, Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Oramed Pharmaceuticals, Inc market cap is $98.82M.
What is the 52-week high for Oramed Pharmaceuticals, Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Oramed Pharmaceuticals, Inc 52 week high is $3.09 as of September 29, 2025.
What is the 52-week low for Oramed Pharmaceuticals, Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Oramed Pharmaceuticals, Inc 52 week low is $1.82 as of September 29, 2025.
What is Oramed Pharmaceuticals, Inc stock price today?
Oramed Pharmaceuticals, Inc stock price today is $2.37.
What was Oramed Pharmaceuticals, Inc stock price yesterday?
Oramed Pharmaceuticals, Inc stock price yesterday was $2.41.
What is the PE ratio of Oramed Pharmaceuticals, Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Oramed Pharmaceuticals, Inc’s P/E ratio is -3.96.
What is the Price-to-Book ratio of Oramed Pharmaceuticals, Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Oramed Pharmaceuticals, Inc P/B ratio is 0.6370.
What is the 50-day moving average of Oramed Pharmaceuticals, Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Oramed Pharmaceuticals, Inc 50-day moving average is $2.21.
How many employess does Oramed Pharmaceuticals, Inc has?
